Ardelyx (ARDX) Other financing activities (2014 - 2023)

Ardelyx (ARDX) reported Other financing activities of $5.0 million for Q4 2023, up 250100.0% quarter-over-quarter from -$2000.0 in Q4 2014.

Ardelyx (ARDX) Other financing activities (2014 - 2023) Analysis & Trends

Ardelyx has reported Other financing activities for 2 years, with the latest figure at $5.0 million in Q4 2023.

For the quarter ending Q4 2023, Other financing activities changed N/A year-over-year to $5.0 million; the trailing twelve-month figure through Dec 2023 stood at $5.0 million (changed N/A YoY), and the FY2023 full-year result was $5.0 million, down 47.81% from the prior year.
Other financing activities for Q4 2023 stood at $5.0 million, up from -$2000.0 in the prior quarter.
The five-year high for Other financing activities was $5.0 million in Q4 2023, with the low at $5.0 million in Q4 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	Ardelyx	1.49 Bn	1.25 Bn	89.66 Mn

Download Data